UniProt ID | JADE1_HUMAN | |
---|---|---|
UniProt AC | Q6IE81 | |
Protein Name | Protein Jade-1 | |
Gene Name | JADE1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 842 | |
Subcellular Localization | Cytoplasm . Nucleus . Cytoplasm, cytoskeleton, cilium basal body . Localizes to the ciliary transition zone. | |
Protein Description | Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Transcriptional coactivator, it may also promote acetylation of nucleosomal histone H4 by KAT5. Promotes apoptosis. May act as a renal tumor suppressor. Negatively regulates canonical Wnt signaling; at least in part, cooperates with NPHP4 in this function.. | |
Protein Sequence | MKRGRLPSSSEDSDDNGSLSTTWSQNSRSQHRRSSCSRHEDRKPSEVFRTDLITAMKLHDSYQLNPDEYYVLADPWRQEWEKGVQVPVSPGTIPQPVARVVSEEKSLMFIRPKKYIVSSGSEPPELGYVDIRTLADSVCRYDLNDMDAAWLELTNEEFKEMGMPELDEYTMERVLEEFEQRCYDNMNHAIETEEGLGIEYDEDVVCDVCQSPDGEDGNEMVFCDKCNICVHQACYGILKVPEGSWLCRTCALGVQPKCLLCPKKGGAMKPTRSGTKWVHVSCALWIPEVSIGSPEKMEPITKVSHIPSSRWALVCSLCNEKFGASIQCSVKNCRTAFHVTCAFDRGLEMKTILAENDEVKFKSYCPKHSSHRKPEESLGKGAAQENGAPECSPRNPLEPFASLEQNREEAHRVSVRKQKLQQLEDEFYTFVNLLDVARALRLPEEVVDFLYQYWKLKRKVNFNKPLITPKKDEEDNLAKREQDVLFRRLQLFTHLRQDLERVRNLTYMVTRREKIKRSVCKVQEQIFNLYTKLLEQERVSGVPSSCSSSSLENMLLFNSPSVGPDAPKIEDLKWHSAFFRKQMGTSLVHSLKKPHKRDPLQNSPGSEGKTLLKQPDLCGRREGMVVPESFLGLEKTFAEARLISAQQKNGVVMPDHGKRRDNRFHCDLIKGDLKDKSFKQSHKPLRSTDVSQRHLDNTRAATSPGVGQSAPGTRKEIVPKCNGSLIKVNYNQTAVKVPTTPASPVKNWGGFRIPKKGERQQQGEAHDGACHQHSDYPYLGLGRVPAKERAKSKLKSDNENDGYVPDVEMSDSESEASEKKCIHTSSTISRRTDIIRRSILAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MKRGRLPSSSEDSDD CCCCCCCCCCCCCCC | 51.60 | 21406692 | |
9 | Phosphorylation | KRGRLPSSSEDSDDN CCCCCCCCCCCCCCC | 35.49 | 21406692 | |
10 | Phosphorylation | RGRLPSSSEDSDDNG CCCCCCCCCCCCCCC | 50.16 | 21406692 | |
13 | Phosphorylation | LPSSSEDSDDNGSLS CCCCCCCCCCCCCCC | 42.69 | 21406692 | |
18 | Phosphorylation | EDSDDNGSLSTTWSQ CCCCCCCCCCCCCCC | 25.96 | 21406692 | |
20 | Phosphorylation | SDDNGSLSTTWSQNS CCCCCCCCCCCCCCC | 26.03 | - | |
43 | Acetylation | CSRHEDRKPSEVFRT CCCCCCCCHHHHCHH | 66.28 | 26051181 | |
45 | Phosphorylation | RHEDRKPSEVFRTDL CCCCCCHHHHCHHHH | 49.80 | 28555341 | |
82 | Ubiquitination | PWRQEWEKGVQVPVS HHHHHHHCCCCCCCC | 66.51 | - | |
89 | Phosphorylation | KGVQVPVSPGTIPQP CCCCCCCCCCCCCCC | 16.13 | 30266825 | |
89 (in isoform 3) | Phosphorylation | - | 16.13 | - | |
92 | Phosphorylation | QVPVSPGTIPQPVAR CCCCCCCCCCCCCEE | 32.63 | 30266825 | |
92 (in isoform 3) | Phosphorylation | - | 32.63 | - | |
102 | Phosphorylation | QPVARVVSEEKSLMF CCCEEECCCCCEEEE | 36.86 | - | |
105 | Ubiquitination | ARVVSEEKSLMFIRP EEECCCCCEEEEECC | 44.85 | - | |
114 | Sumoylation | LMFIRPKKYIVSSGS EEEECCCEEEEECCC | 42.78 | - | |
114 | Sumoylation | LMFIRPKKYIVSSGS EEEECCCEEEEECCC | 42.78 | 28112733 | |
114 | Ubiquitination | LMFIRPKKYIVSSGS EEEECCCEEEEECCC | 42.78 | - | |
121 | Phosphorylation | KYIVSSGSEPPELGY EEEEECCCCCCCCCC | 49.21 | - | |
257 | Acetylation | CALGVQPKCLLCPKK CCCCCCCCEEECCCC | 22.03 | 26051181 | |
257 | Ubiquitination | CALGVQPKCLLCPKK CCCCCCCCEEECCCC | 22.03 | - | |
263 | Acetylation | PKCLLCPKKGGAMKP CCEEECCCCCCCCCC | 64.15 | 25953088 | |
293 | Phosphorylation | IPEVSIGSPEKMEPI CCCCCCCCHHHCCCC | 28.37 | 27422710 | |
302 | Ubiquitination | EKMEPITKVSHIPSS HHCCCCCEECCCCHH | 42.32 | - | |
302 | Acetylation | EKMEPITKVSHIPSS HHCCCCCEECCCCHH | 42.32 | 23749302 | |
331 | Acetylation | ASIQCSVKNCRTAFH CEEEEEECCCCHHEE | 33.75 | 25953088 | |
360 | Acetylation | LAENDEVKFKSYCPK EECCCCEEEHHHCCC | 45.05 | 26051181 | |
360 | Ubiquitination | LAENDEVKFKSYCPK EECCCCEEEHHHCCC | 45.05 | - | |
363 | Phosphorylation | NDEVKFKSYCPKHSS CCCEEEHHHCCCCCC | 34.79 | 29116813 | |
364 | Phosphorylation | DEVKFKSYCPKHSSH CCEEEHHHCCCCCCC | 17.23 | 21964256 | |
373 | Acetylation | PKHSSHRKPEESLGK CCCCCCCCCHHHCCC | 51.89 | 23236377 | |
377 | Phosphorylation | SHRKPEESLGKGAAQ CCCCCHHHCCCCHHH | 40.54 | 29116813 | |
380 | Ubiquitination | KPEESLGKGAAQENG CCHHHCCCCHHHHCC | 51.15 | - | |
380 | Acetylation | KPEESLGKGAAQENG CCHHHCCCCHHHHCC | 51.15 | 23749302 | |
392 (in isoform 3) | Phosphorylation | - | 25.82 | - | |
392 | Phosphorylation | ENGAPECSPRNPLEP HCCCCCCCCCCCCCC | 25.82 | 29255136 | |
402 | Phosphorylation | NPLEPFASLEQNREE CCCCCCCCHHHHHHH | 32.58 | 26074081 | |
468 | Phosphorylation | NFNKPLITPKKDEED CCCCCCCCCCCCHHC | 36.42 | 23312004 | |
470 | Acetylation | NKPLITPKKDEEDNL CCCCCCCCCCHHCCH | 65.29 | 19811757 | |
493 | Phosphorylation | FRRLQLFTHLRQDLE HHHHHHHHHHHHHHH | 28.70 | 20068231 | |
501 | Methylation | HLRQDLERVRNLTYM HHHHHHHHHHCCHHH | 39.74 | 24376903 | |
501 | Dimethylation | HLRQDLERVRNLTYM HHHHHHHHHHCCHHH | 39.74 | - | |
503 | Methylation | RQDLERVRNLTYMVT HHHHHHHHCCHHHHH | 38.37 | 24376911 | |
503 | Dimethylation | RQDLERVRNLTYMVT HHHHHHHHCCHHHHH | 38.37 | - | |
507 | Phosphorylation | ERVRNLTYMVTRREK HHHHCCHHHHHCHHH | 7.86 | 22817900 | |
532 | Ubiquitination | QIFNLYTKLLEQERV HHHHHHHHHHHHHHH | 37.20 | - | |
547 | Phosphorylation | SGVPSSCSSSSLENM CCCCCCCCCHHHHHH | 34.89 | 27251275 | |
548 | Phosphorylation | GVPSSCSSSSLENML CCCCCCCCHHHHHHH | 28.42 | 27251275 | |
549 | Phosphorylation | VPSSCSSSSLENMLL CCCCCCCHHHHHHHC | 23.73 | 27251275 | |
550 | Phosphorylation | PSSCSSSSLENMLLF CCCCCCHHHHHHHCC | 41.47 | 27251275 | |
559 | Phosphorylation | ENMLLFNSPSVGPDA HHHHCCCCCCCCCCC | 15.95 | 27251275 | |
561 | Phosphorylation | MLLFNSPSVGPDAPK HHCCCCCCCCCCCCC | 39.26 | 27251275 | |
573 | Sumoylation | APKIEDLKWHSAFFR CCCHHHCCHHHHHHH | 56.00 | 28112733 | |
585 | Phosphorylation | FFRKQMGTSLVHSLK HHHHHHCCHHHHHCC | 17.34 | 21406692 | |
586 | Phosphorylation | FRKQMGTSLVHSLKK HHHHHCCHHHHHCCC | 23.75 | 21406692 | |
590 | Phosphorylation | MGTSLVHSLKKPHKR HCCHHHHHCCCCCCC | 34.11 | 25159151 | |
603 | Phosphorylation | KRDPLQNSPGSEGKT CCCCCCCCCCCCCCC | 20.06 | 23401153 | |
606 | Phosphorylation | PLQNSPGSEGKTLLK CCCCCCCCCCCCHHC | 46.70 | 30266825 | |
609 | Acetylation | NSPGSEGKTLLKQPD CCCCCCCCCHHCCCC | 31.76 | 25953088 | |
610 | Phosphorylation | SPGSEGKTLLKQPDL CCCCCCCCHHCCCCC | 48.45 | 28111955 | |
702 | Phosphorylation | LDNTRAATSPGVGQS HHCCCCCCCCCCCCC | 34.17 | 30266825 | |
703 | Phosphorylation | DNTRAATSPGVGQSA HCCCCCCCCCCCCCC | 18.22 | 30266825 | |
709 | Phosphorylation | TSPGVGQSAPGTRKE CCCCCCCCCCCCCCC | 30.42 | 30266825 | |
713 | Phosphorylation | VGQSAPGTRKEIVPK CCCCCCCCCCCCCCC | 37.19 | 29396449 | |
724 | Phosphorylation | IVPKCNGSLIKVNYN CCCCCCCCEEEEECC | 16.96 | 24719451 | |
739 | Phosphorylation | QTAVKVPTTPASPVK CCEEECCCCCCCCCC | 48.69 | 21712546 | |
740 | Phosphorylation | TAVKVPTTPASPVKN CEEECCCCCCCCCCC | 15.70 | 30266825 | |
743 | Phosphorylation | KVPTTPASPVKNWGG ECCCCCCCCCCCCCC | 31.28 | 30266825 | |
796 | Phosphorylation | RAKSKLKSDNENDGY HHHHHCCCCCCCCCC | 56.98 | 25278378 | |
803 | Phosphorylation | SDNENDGYVPDVEMS CCCCCCCCCCCCCCC | 16.21 | 25278378 | |
810 | Phosphorylation | YVPDVEMSDSESEAS CCCCCCCCCCCCHHH | 25.20 | 30576142 | |
812 | Phosphorylation | PDVEMSDSESEASEK CCCCCCCCCCHHHHH | 35.40 | 30576142 | |
814 | Phosphorylation | VEMSDSESEASEKKC CCCCCCCCHHHHHHH | 42.27 | 30576142 | |
817 | Phosphorylation | SDSESEASEKKCIHT CCCCCHHHHHHHCCC | 45.99 | 30576142 | |
824 | Phosphorylation | SEKKCIHTSSTISRR HHHHHCCCCCHHHHH | 12.40 | 20068231 | |
825 | Phosphorylation | EKKCIHTSSTISRRT HHHHCCCCCHHHHHH | 16.01 | 20068231 | |
826 | Phosphorylation | KKCIHTSSTISRRTD HHHCCCCCHHHHHHH | 30.80 | 20068231 | |
827 | Phosphorylation | KCIHTSSTISRRTDI HHCCCCCHHHHHHHH | 23.80 | 20068231 | |
829 | Phosphorylation | IHTSSTISRRTDIIR CCCCCHHHHHHHHHH | 18.79 | 20068231 | |
832 | Phosphorylation | SSTISRRTDIIRRSI CCHHHHHHHHHHHHH | 30.36 | 24702127 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of JADE1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of JADE1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89; THR-92 AND SER-603,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89 AND SER-743, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89 AND THR-92, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-9; SER-10 ANDSER-13, AND MASS SPECTROMETRY. |